Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report)’s stock price rose 4.2% during trading on Wednesday . The company traded as high as $3.01 and last traded at $3.01. Approximately 171 shares were traded during trading, a decline of 93% from the average daily volume of 2,325 shares. The stock had previously closed at $2.89.
Relief Therapeutics Stock Performance
The business has a fifty day simple moving average of $1.91 and a two-hundred day simple moving average of $1.58.
About Relief Therapeutics
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Read More
- Five stocks we like better than Relief Therapeutics
- Short Selling: How to Short a Stock
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- What is the Shanghai Stock Exchange Composite Index?
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- Dividend Payout Ratio Calculator
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
